FindTrial
Sign In

Comparison of the Effect of two groups of antidepressants on the body mass index in patients on long term treatment.

Comparison of the Effect of Selective Serotonin Reuptake Inhibitors and Selective Serotonin Norepinephrine Reuptake Inhibitors on Body Mass Index in patients on long term treatment.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2014/07/004785
Enrollment
60
Registered
2014-07-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients on antidepressants with various Psychiatric illness

Interventions

Control Intervention1: Group A: Patients on monotherapy with Selective Serotonin Reuptake Inhibitors (SSRIs) -Either sertraline or fluoxetine or escitalopram Control Intervention2: Group B: Patients o

Sponsors

Dr Shreya Hegde
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients on monotherapy with sertraline or fluoxetine or escitalopram or venlafaxine or desvenlafaxine or duloxetine. The patient should have been on treatment with the particular antidepressant continuously for a minimum of six months.

Exclusion criteria

Exclusion criteria: Patients 65 years. Patients with co morbid medical conditions. Patients on long term treatment with other medications.

Design outcomes

Primary

MeasureTime frame
To record the changes in weight and Body Mass Index in patients on monotherapy with one the SSRI or SNRI mentioned above.Timepoint: 1 year—

Secondary

MeasureTime frame
To compare the effect of SSRIs and SNRIs on body mass index.Timepoint: 1 year—

Countries

India

Contacts

Public ContactDr Padmaja Udaykumar

Father Muller Medical College

padmajaudaykumar@gmail.com09880890512

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026